BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2868857)

  • 1. Serum protein binding of a new oral cephalosporin, CL 284,635, in various species.
    Bialer M; Tonelli AP; Kantrowitz JD; Yacobi A
    Drug Metab Dispos; 1986; 14(1):132-6. PubMed ID: 2868857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of ceftriaxone.
    Popick AC; Crouthamel WG; Bekersky I
    Xenobiotica; 1987 Oct; 17(10):1139-45. PubMed ID: 3424863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro plasma protein binding of propafenone and protein profile in eight mammalian species.
    Puigdemont A; Arboix M; Gaspari F; Bortolotti A; Bonati M
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):435-40. PubMed ID: 2781140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding characteristics of a new bronchodilator, 1-methyl-3-propylxanthine (MPX), in different species.
    Apichartpichean R; Takagi K; Kuzuya T; Nadai M; Ohshima T; Suzuki K; Horiuchi T; Miyamoto K; Hasegawa T
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):320-3. PubMed ID: 2777419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.
    Löscher W
    J Pharmacol Exp Ther; 1978 Feb; 204(2):255-61. PubMed ID: 340640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear kinetics of alendronate. Plasma protein binding and bone uptake.
    Lin JH; Chen IW; deLuna FA
    Drug Metab Dispos; 1994; 22(3):400-5. PubMed ID: 8070316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM; Mayersohn M; Woodworth JR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.
    Acharya MR; Sparreboom A; Sausville EA; Conley BA; Doroshow JH; Venitz J; Figg WD
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):275-81. PubMed ID: 16028097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of albumin concentration, albumin species, pH and temperature on the stereoselectively different binding of (S)-(+)- and (R)-(-)-1-methyl-5-phenyl-5-propyl-barbiturate to serum albumin.
    Büch HP; Knabe J; Krug R
    Arzneimittelforschung; 1995 Oct; 45(10):1049-53. PubMed ID: 8595055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species variations in the proportions of ultrafiltrable and protein-bound serum nickel.
    Hendel RC; Sunderman FW
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):141-6. PubMed ID: 4671994
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative study of total protein and albumin in man, monkey, dog and rat employing different analytical methods (author's transl)].
    Metz A; Schütze A
    Z Klin Chem Klin Biochem; 1975 Sep; 13(9):423-6. PubMed ID: 812278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective plasma protein binding of bimoclomol.
    Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
    Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.
    Obach RS
    Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
    Bialer M; Batra VK; Morrison JA; Silber BM; Look ZM; Yacobi A
    Pharm Res; 1987 Feb; 4(1):33-7. PubMed ID: 3508527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M; Bertucci C
    Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new aspect of serum protein binding of tolbutamide.
    Ayanoğlu G; Uihlein M; Grigoleit HG
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):65-8. PubMed ID: 3957494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species-dependent enantioselective plasma protein binding of MK-571, a potent leukotriene D4 antagonist.
    Lin JH; deLuna FA; Ulm EH; Tocco DJ
    Drug Metab Dispos; 1990; 18(4):484-7. PubMed ID: 1976072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of abouthiouzine: a novel antihyperthyroid drug.
    Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
    Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.